← All medicines
Salofalk 3g prolonged-release granules
Licence PA0573/003/006 · Marketed
- Licence holder
- Dr. Falk Pharma GmbH (all products →)
- Active substance
- Mesalazine
- Dosage form
- Prolonged-release granules
- Route of administration
- Oral use
- ATC codes
- A07EC, A07EC02
- First authorised
- 15/07/2011
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.